Metabolic effects of high dose corticosteroids

Area of Science:

• Biochemistry
• Pathophysiology
• Endocrinology

Background:

• Septic shock involves complex metabolic derangements, including glycogen depletion and impaired glucose production, exacerbated by endotoxins.
• Endotoxins exhibit antiglucocorticoid effects, contributing to hypoglycemia and mitochondrial dysfunction in septic states.
• Current understanding of the detailed metabolic pathology in shock remains incomplete.

Purpose of the Study:

• To elucidate the metabolic effects of high-dose corticosteroids (HDC) in septic shock.
• To investigate how HDC counteracts endotoxin-induced metabolic alterations.
• To understand the mechanisms behind improved survival in septic shock treated with HDC.

Main Methods:

• Analysis of metabolic pathways, including glycolysis (Embden-Meyerhof pathway) and the hexose monophosphate shunt.
• Measurement of key metabolites such as glycogen, hexose phosphates, phosphoenol-pyruvate, fructose diphosphate, phosphoglycerates, lactate, pyruvate, and Krebs cycle intermediates.
• Assessment of mitochondrial function and cellular energy production.

Main Results:

• HDC counteracts accelerated glycolysis and prevents endotoxin-induced stimulation of the hexose monophosphate shunt.
• HDC treatment increases liver levels of Krebs cycle intermediates and pyruvate, indicating enhanced gluconeogenesis.
• HDC improves the lactate/pyruvate ratio, stimulates protein catabolism for gluconeogenesis, reverses mitochondrial dysfunction, and enhances cellular energy production.

Conclusions:

• HDC exerts beneficial metabolic effects in septic shock by normalizing glucose metabolism and improving mitochondrial function.
• HDC's actions include enhancing gluconeogenesis and protein catabolism, crucial for energy restoration.
• Indirect effects of HDC, such as reduced fever and improved tissue oxygenation, may also contribute to improved outcomes.